How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/diffuse-proliferative-lupus-nephritis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Diffuse Proliferative Lupus Nephritis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diffuse Proliferative Lupus Nephritis (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Diffuse Proliferative Lupus Nephritis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Deltasone	prednisone	Generic (originally Schering)	Corticosteroid [EPC]	Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor		1955-01-01
prednison	prednison	Wen Zhang		Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Generic (originally Schering) · 1 drug in Diffuse Proliferative Lupus Nephritis
Wen Zhang · 1 drug in Diffuse Proliferative Lupus Nephritis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Diffuse Proliferative Lupus Nephritis:

Cite this brief

Drug Landscape (2026). Diffuse Proliferative Lupus Nephritis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/diffuse-proliferative-lupus-nephritis. Accessed 2026-06-10.

Diffuse Proliferative Lupus Nephritis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing